Gene Editing Technology

• 10/25/2024

  Cathie Wood’s Top 3 Stock Picks: Amazon, 3D Systems, and CRISPR Therapeutics

• 10/25/2024

  “Revolutionizing Gene Editing: Editas Medicine’s Strategic Update”

• 10/25/2024

  “Revolutionizing Disease Treatment: The $10 Billion Gene Editing Opportunity”

• 10/23/2024

  3 Undervalued Stocks to Buy in a Pricey Market

• 10/23/2024

  Biotech’s Bright Future: 2024 Outlook and Emerging Trends

• 10/9/2024

  **2 Stocks with Massive Upside Potential: 32% and 282% Gains Forecasted**

• 10/1/2024

  **Editas Medicine Presents at 8th Annual Genetic Medicines Conference (Transcript)**

• 9/30/2024

  **CB-010 and chRDNA Technology Show Promise in Gene Editing**

• 9/29/2024

  **2 High-Risk, High-Reward Stocks to Buy**

• 9/29/2024

  **Beam Therapeutics: Overvalued and Not a Buy**